We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Mylan, J&J In Authorized Generics Deal Over Ditropan XL

Law360 (December 20, 2005, 12:00 AM EST) -- Generic drug maker Mylan Laboratories and Johnson & Johnson subsidiary Alza have entered into an agreement over the rights to market a generic version of overactive bladder treatment Ditropan XL, adding...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.